7 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32426479 | RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease. | 2020 May | 3 |
2 | 29992529 | MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson's Disease Patients. | 2019 Mar | 2 |
3 | 32146463 | Regulation of Protein Synthesis and Apoptosis in Lymphocytes of Parkinson Patients: The Effect of Dopaminergic Treatment. | 2019 | 1 |
4 | 24144882 | New genetic insights highlight 'old' ideas on motor dysfunction in dystonia. | 2013 Dec | 1 |
5 | 22179112 | Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. | 2011 Dec 18 | 2 |
6 | 19622830 | Thwarting dyskinesia by targeting mTORC1. | 2009 Jul 21 | 1 |
7 | 19622833 | Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. | 2009 Jul 21 | 2 |